| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4312634 | Behavioural Brain Research | 2013 | 7 Pages |
Abstract
The results show pharmacological activity modifying the EPM in low doses suggesting the use in treatment of behavioral traits and symptoms represented by or linked to the EPM including anxiety-related behavior including depression. Compounds acting at higher doses may be used to induce behavioral changes and thus serve as neurobiological-neuropharmacological tools.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Ajinkya Sase, Hans Brückner, Harald Höger, Arnold Pollak, Gert Lubec,